Home > Compound List > Compound details
41708-72-9 molecular structure
click picture or here to close

2-amino-N-(2,6-dimethylphenyl)propanamide

ChemBase ID: 927
Molecular Formular: C11H16N2O
Molecular Mass: 192.25754
Monoisotopic Mass: 192.12626314
SMILES and InChIs

SMILES:
O=C(Nc1c(cccc1C)C)C(N)C
Canonical SMILES:
CC(C(=O)Nc1c(C)cccc1C)N
InChI:
InChI=1S/C11H16N2O/c1-7-5-4-6-8(2)10(7)13-11(14)9(3)12/h4-6,9H,12H2,1-3H3,(H,13,14)
InChIKey:
BUJAGSGYPOAWEI-UHFFFAOYSA-N

Cite this record

CBID:927 http://www.chembase.cn/molecule-927.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
2-amino-N-(2,6-dimethylphenyl)propanamide
IUPAC Traditional name
tocainide
Brand Name
Tonocard
Synonyms
Tocainida [INN-Spanish]
Tocainidum [INN-Latin]
Tocainide
CAS Number
41708-72-9
PubChem SID
160964390
46505385
PubChem CID
38945

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID
DrugBank DB01056 external link
PubChem 38945 external link
Data Source Data ID Price

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa 13.653854  H Acceptors
H Donor LogD (pH = 5.5) -0.6713139 
LogD (pH = 7.4) 0.9973883  Log P 1.8824334 
Molar Refractivity 58.857 cm3 Polarizability 22.107647 Å3
Polar Surface Area 55.12 Å2 Rotatable Bonds
Lipinski's Rule of Five true 
Log P 0.55  LOG S -2.08 
Solubility (Water) 1.60e+00 g/l 

PROPERTIES

PROPERTIES

Physical Property Bioassay(PubChem)
Solubility
1.07E+004 mg/L expand Show data source
Hydrophobicity(logP)
1.1 expand Show data source

DETAILS

DETAILS

DrugBank DrugBank
DrugBank - DB01056 external link
Item Information
Drug Groups approved
Description An antiarrhythmic agent which exerts a potential- and frequency-dependent block of sodium channels. [PubChem]
Indication For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening.
Pharmacology Tocainide is a primary amine analog of lidocaine with antiarrhythmic properties useful in the treatment of ventricular arrhythmias. Tocainide, like lidocaine, produces dose dependent decreases in sodium and potassium conductance, thereby decreasing the excitability of myocardial cells. In experimental animal models, the dose-related depression of sodium current is more pronounced in ischemic tissue than in normal tissue. Tocainide is a Class I antiarrhythmic compound with electrophysiologic properties in man similar to those of lidocaine, but dissimilar from quinidine, procainamide, and disopyramide.
Toxicity The oral LD50 of tocainide was calculated to be about 800 mg/kg in mice, 1000 mg/kg in rats, and 230 mg/kg in guinea pigs; deaths were usually preceded by convulsions.
Affected Organisms
Humans and other mammals
Biotransformation Negligible first pass hepatic degradation. No active metabolites have been found.
Absorption Following oral administration, the bioavailability approaches 100 percent, and is unaffected by food.
Half Life The average plasma half-life in patients is approximately 15 hours. May be prolonged up to 35 hours in patients with severe renal function impairment (creatinine clearance less than 30 mL per min per 1.73 square meters of body surface area.
Protein Binding Approximately 10 percent bound to plasma protein.
External Links
Wikipedia
RxList
PDRhealth
Drugs.com

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle